Zenlabs Ethica Partners with V Nexxtra for Exclusive Distribution

Zenlabs Ethica has appointed V Nexxtra Lifesciences as its sole and exclusive distributor, covering the entire territory for its full product portfolio. This strategic agreement aims to significantly strengthen Zenlabs Ethica’s sales and distribution network, enhancing its market footprint. The partnership is designed to improve customer reach through a dedicated and specialized marketing channel.

V Nexxtra’s Exclusive Mandate

Under the new terms, V Nexxtra Lifesciences will exclusively manage the sale, marketing promotion, and distribution of all products from Zenlabs Ethica and its subsidiaries. V Nexxtra is also designated as the sole agent for Zenlabs Ethica, with a clear restriction: they cannot engage in similar marketing activities for any other company without mutual consent or approval from Zenlabs Ethica.

• Sales planning and forecasting
• Market development
• Collection of orders and payments
• Ensuring compliance with relevant laws and regulations

Financials and Strategic Goals

V Nexxtra Lifesciences will pay Zenlabs Ethica a margin based on its sales. These payments are consistently due on or before the 10th day of the succeeding month, each accompanied by the relevant sales/purchase statement.

• Margin: 5% of Net Sales Value (exclusive of GST)

• Strengthen sales and distribution network
• Enhance market penetration
• Improve customer reach through a specialized marketing channel

Zenlabs Ethica’s product line includes various branded drugs, all manufactured by Zenlabs Pharmaceuticals Inc. These products adhere strictly to prescribed international standards and norms, now poised for broader reach through this dedicated marketing channel.